Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

Pre-emptive pharmacogenomic (PGx) testing of a panel of genes may be easier to implement and more cost-effective than reactive pharmacogenomic testing if a sufficient number of medications are covered by a single test and future medication exposure can be anticipated. We analysed the incidence of ex...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one Jg. 11; H. 10; S. e0164972
Hauptverfasser:	Samwald, Matthias, Xu, Hong, Blagec, Kathrin, Empey, Philip E., Malone, Daniel C., Ahmed, Seid Mussa, Ryan, Patrick, Hofer, Sebastian, Boyce, Richard D.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Public Library of Science 20.10.2016 Public Library of Science (PLoS)
Schlagworte:	Adolescent Adult Aged Artificial intelligence Biology and Life Sciences Child Child, Preschool Complications and side effects Consortia Cost analysis Cost-Benefit Analysis Databases, Factual Drug dosages Drug Prescriptions - economics Drug Prescriptions - statistics & numerical data Drug therapy Drug-Related Side Effects and Adverse Reactions - economics Drugs Ethnicity Exposure Female Genotype & phenotype Government programs Guidelines Health care Humans Incidence Infant Infant, Newborn Informatics Internet Male Medicaid Medical screening Medical statistics Medicine and Health Sciences Middle Aged Patients Pharmacogenomic Testing Pharmacogenomics Pharmacology Pharmacy Practice guidelines (Medicine) Practice Guidelines as Topic Prescription drugs R&D Research & development Risk Social Sciences Studies United States Young Adult New York Austria Pittsburgh Pennsylvania United States > US Pennsylvania
ISSN:	1932-6203, 1932-6203
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!